Review
Published on 07 Feb 2020
PARP Inhibitors in Prostate and Urothelial Cancers
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00114
- 10,589 views
- 17 citations
25 articles related to "Polyadp Ribose Polymerase Parp"
Articles
Mini Review
Published on 27 Feb 2013
Resistance to PARP-Inhibitors in Cancer Therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00018
- 18,542 views
- 93 citations
Original Research
Published on 01 Nov 2018
Nuclear Import of Arabidopsis Poly(ADP-Ribose) Polymerase 2 Is Mediated by Importin-α and a Nuclear Localization Sequence Located Between the Predicted SAP Domains
in Plant Cell Biology
Frontiers in Plant Science
doi 10.3389/fpls.2018.01581
- 7,771 views
- 26 citations
Original Research
Published on 06 Jul 2022
Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer Activity
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2022.842316
- 4,121 views
- 14 citations
Mini Review
Published on 23 Nov 2020
Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
in Medicinal and Pharmaceutical Chemistry
Frontiers in Chemistry
doi 10.3389/fchem.2020.594619
- 7,926 views
- 19 citations
Review
Published on 28 Aug 2020
Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) – Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy
in Cellular Biochemistry
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2020.00191
- 34,641 views
- 107 citations
Case Report
Published on 29 Apr 2022
Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.873198
- 11,060 views
- 19 citations
Review
Published on 06 Aug 2025
PARP inhibitors in melanoma treatment: potential, challenges, and future directions
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1552386
- 3,198 views
- 1 citation
Review
Published on 14 Oct 2021
Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.675972
- 12,010 views
- 37 citations
Original Research
Published on 03 Jun 2022
Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.821366
- 6,750 views
- 15 citations
Original Research
Published on 07 Dec 2021
PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2021.724104
- 7,786 views
- 30 citations
Review
Published on 01 Oct 2013
The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2013.00237
- 19,861 views
- 54 citations
Original Research
Published on 22 Feb 2023
PARP inhibitors in the treatment of ARID1A mutant ovarian clear cell cancer: PI3K/Akt1-dependent mechanism of synthetic lethality
in Gynecological Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1124147
- 7,308 views
- 15 citations
Review
Published on 01 Dec 2022
The potential of PARP inhibitors in targeted cancer therapy and immunotherapy
in Molecular Diagnostics and Therapeutics
Frontiers in Molecular Biosciences
doi 10.3389/fmolb.2022.1073797
- 12,765 views
- 33 citations
Review
Published on 05 May 2020
Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.00670
- 14,050 views
- 21 citations
Original Research
Published on 16 Aug 2022
Effectiveness of PARP inhibition in enhancing the radiosensitivity of 3D spheroids of head and neck squamous cell carcinoma
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2022.940377
- 6,260 views
- 18 citations